Zhongzhi Pharmaceutical (3737.HK) Annual Report Review: Strong Growth in Broken Walls, Revenue Accelerated Across the Board
安信國際Apr 8, 2018 00:00
Zhongzhi Pharmaceutical (3737.HK): Marketing reforms and policy dividends both benefit
安信國際Nov 26, 2017 00:00
Zhongzhi Pharmaceutical (3737.HK): Potential blockbuster products in the novel tablet segment
招銀國際Sep 12, 2017 00:00
Zhongzhi Pharmaceutical (3737.HK): The impact of additional advertisements on long-term profits is still promising
安信國際Jun 30, 2016 00:00
Summary of the reverse roadshow of 3737.HK
交銀國際Oct 23, 2015 00:00
No Data
No Data